The Regenexx blog recently looked at the differences between medical innovation and classified them into two categories: pragmatic and research based. Pragmatic innovation mainly affects one individual and one doctor, as it is a very singular based trail. However, with research based innovation in the clinical field, clinical trials are often tested on large groups of people.
The article states:
One pathway can lead to the other, as it’s common for doctors who discover new techniques to test these via controlled trials. The opposite is also true, as research findings that seem to hold great promise in controlled trials fail to work as well in real world medical practice. This last problem is very common, as physicians in the field often find that the single variable study design doesn’t apply to their multivariate patient populations. There is societal benefit to make sure that both of these discovery pathways thrive, as both benefit medical innovation.
What do you think of the authors beliefs? Do you agree or disagree?
Read the full article here.
About:
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is an extension of the Partnerships in Clinical Trials Conference.
As a reader of the Partnerships in Clinical Trials blog, mention code XP1718BLOG when registering to join us in Sao Paulo for Partnerships in Clinical Trials Latin America to receive a discount of $100 off the current rate!
Would you like to guest blog on our site? Or send us feedback? Send an email to jpereira@iirusa.com.



.gif)
0 comments:
Post a Comment